Drug intelligence / Profile preview

thiamine hydrochloride + methylnicotinate

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Topical
01

Overview

thiamine hydrochloride + methylnicotinate is a topical pharmaceutical combination used for the symptomatic relief of musculoskeletal pain, including myalgia, neuralgia, and joint pain. Methyl nicotinate acts as a rubefacient and potent vasodilator; upon topical application, it induces local hyperemia and a warming sensation that serves as a counter-irritant to alleviate deeper pain. Thiamine hydrochloride (Vitamin B1) is included to support local metabolic processes and nerve health. This combination is most notably marketed under the brand name Algipan in certain European markets, such as Italy, where it is indicated for various minor sports injuries and rheumatic conditions.

Brand names
Algipan
Other names
thiamine hydrochloridemethylnicotinatemethyl nicotinateVitamin B1 + methyl nicotinate
02

Targets

Thiamine pyrophosphate-dependent metabolic enzymesTPK1 (Thiamine pyrophosphokinase 1)

Beyond the preview

Go deeper on thiamine hydrochloride + methylnicotinate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thiamine hydrochloride + methylnicotinate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call